Active surveillance in prostate cancer: current and potentially emerging biomarkers for patient selection criteria
PC Sotomayor, JC Aguilar, K Mujica, A Zuñiga… - Urologia …, 2022 - karger.com
Abstract Background: Prostate cancer (PCa) represents one of the most frequent
malignancies and the fifth leading cause of cancer death in adult men worldwide. PCa …
malignancies and the fifth leading cause of cancer death in adult men worldwide. PCa …
The relationship between PSA and total testosterone levels in men with prostate cancer
JM Flores, HL Bernie, E Miranda… - The journal of sexual …, 2022 - academic.oup.com
Background Prostate-specific antigen (PSA) secretion is a testosterone (T) dependent
process. Published data suggest that a low T level is an independent predictor of higher …
process. Published data suggest that a low T level is an independent predictor of higher …
Increased body mass index is a risk factor for poor clinical outcomes after radical prostatectomy in men with International Society of Urological Pathology grade group …
M Ferro, D Terracciano, G Musi, O de Cobelli… - Urologia …, 2022 - karger.com
Introduction: The association between obesity and clinically significant prostate cancer
(PCa) is still a matter of debate. In this study, we evaluated the effect of body mass index …
(PCa) is still a matter of debate. In this study, we evaluated the effect of body mass index …
[HTML][HTML] Low serum total testosterone level as a predictor of upgrading in low-risk prostate cancer patients after radical prostatectomy: A systematic review and meta …
S Gan, J Liu, Z Chen, S Xiang, C Gu, S Li… - … and Clinical Urology, 2022 - ncbi.nlm.nih.gov
Purpose To investigated the association between serum total testosterone and Gleason
score upgrading of low-risk prostate cancer after radical prostatectomy (RP). Materials and …
score upgrading of low-risk prostate cancer after radical prostatectomy (RP). Materials and …
Urinary Metabolomic Fingerprints as a Powerful Tool for the Next Generation of Prostate Cancer Diagnosis
CV Berenguer - 2022 - search.proquest.com
Prostate cancer (PCa) remains the most frequent malignant tumour and a leading cause of
oncological death in men, despite the spectacular advances in molecular medicine …
oncological death in men, despite the spectacular advances in molecular medicine …